Lincoln Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Lincoln Pharmaceuticals has a total shareholder equity of ₹6.4B and total debt of ₹13.6M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are ₹7.8B and ₹1.4B respectively. Lincoln Pharmaceuticals's EBIT is ₹875.0M making its interest coverage ratio -14.3. It has cash and short-term investments of ₹2.0B.
Key information
0.2%
Debt to equity ratio
₹13.55m
Debt
| Interest coverage ratio | -14.3x |
| Cash | ₹1.97b |
| Equity | ₹6.39b |
| Total liabilities | ₹1.41b |
| Total assets | ₹7.80b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 531633's short term assets (₹5.2B) exceed its short term liabilities (₹1.2B).
Long Term Liabilities: 531633's short term assets (₹5.2B) exceed its long term liabilities (₹200.9M).
Debt to Equity History and Analysis
Debt Level: 531633 has more cash than its total debt.
Reducing Debt: 531633's debt to equity ratio has reduced from 12.3% to 0.2% over the past 5 years.
Debt Coverage: 531633's debt is well covered by operating cash flow (4772.1%).
Interest Coverage: 531633 earns more interest than it pays, so coverage of interest payments is not a concern.